Cristi Radford, MS, CGC
Product Director, Optum
Cristi Radford, MS, CGC, Product Director, is part of the team developing and launching genetic test management capabilities within Optum’s laboratory benefit management solution. Previously, Ms. Radford served as Director of Genetics, Clinical Initiatives for UnitedHealthcare, where she was responsible for developing and implementing strategies to improve access to genetic testing and services while driving affordability and member outcomes. Of note, she spearheaded the launch of Fit-at-50, a program increasing the use of direct-to-member, in-home, colorectal cancer screening for average risk members, setting a framework for precision population health programs. She also led the implementation of a rapid genetic testing program in the NICU setting, which increased the use of rapid genetic testing in NICU settings using a novel reimbursement method.
Prior to joining UnitedHealth Group, Ms. Radford was Channel Development Manager at Genome Medical. Earlier in her career, Radford developed several community-based cancer risk assessment programs before transitioning into commercial molecular diagnostics in 2012 at Ambry Genetics and subsequently Invitae.
Her academic roles have included positions at Vanderbilt University and Moffit Cancer Center, where she helped create and expand ICARE, as well as Johns Hopkins University.